Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects

European Journal of Human Genetics - Tập 21 Số 11 - Trang 1219-1225 - 2013
Corry M.R. Weemaes1, Maarten JD van Tol2, Jun Wang3,4, Monique M. van Ostaijen-ten Dam2, Marja CJA van Eggermond5, Peter Thijssen4, Caner Aytekin6, Nicola Brunetti‐Pierri7, Mirjam van der Burg8, E. Graham Davies9, Alina Ferster10, Dieter Furthner11, Giorgio Gimelli12, A Gennery13, Barbara Kloeckener‐Gruissem14,15, M. Stephen Meyn16, Cynthia M. Powell17, İsmail Reisli18, Catharina Schuetz19, Ansgar Schulz19, Andrea Shugar16, Peter J. van den Elsen5,20, Silvère M. van der Maarel4
1Department of Pediatric Infectious Diseases and Immunology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
2Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands
320Current address: Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China.,
4Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands
5Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands
6Department of Pediatric Immunology, Dr. Sami Ulus Maternity and Children’s, Research and Educational Hospital, Ankara, Turkey
7Department of Pediatrics, “Federico II” University of Naples, Naples, Italy
8Department of Immunology, Erasmus Medical Center, Rotterdam, The Netherlands
9Centre for Immunodeficiency, Great Ormond Street Hospital and Institute of Child Health, London, UK
10Department of Pediatrics, Haemato-Oncology Unit, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Brussels, Belgium
11Landesfrauen und Kinderklinik, Linz, Austria
12Laboratorio di Citogenetica, Instituto G Gaslini, Genova, Italy
13Department of Paediatric Immunology, Newcastle Upon Tyne Hospital, NHS Foundation Trust, United Kingdom and Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, UK
14Department of Biology, ETHZ, Zurich, Switzerland;
15Institute of Medical Molecular Genetics, University of Zurich, Zurich, Switzerland
16Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, Canada
17Department of Pediatrics, The University of North Carolina at Chapel Hill, Chapel Hill, USA
18Department of Pediatric Immunology and Allergy, Necmettin Erbakan University, Meram Medical Faculty, Konya, Turkey
19Department of Pediatrics and Adolescent Medicine, University Hospital Ulm, Ulm, Germany
20Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands

Tóm tắt

Từ khóa


Tài liệu tham khảo

Hagleitner MM, Lankester A, Maraschio P et al: Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome). J Med Genet 2008; 45: 93–99.

Blanco-Betancourt CE, Moncla A, Milili M et al: Defective B-cell-negative selection and terminal differentiation in the ICF syndrome. Blood 2004; 103: 2683–2690.

Pezzolo A, Prigione I, Facchetti P et al: T-cell apoptosis in ICF syndrome. J Allergy Clin Immunol 2001; 108: 310–312.

Pezzolo A, Prigione I, Chiesa S et al: A novel case of immunodeficiency, centromeric instability, and facial anomalies (the ICF syndrome): immunologic and cytogenetic studies. Haematologica 2002; 87: 329–331.

Hansen RS, Wijmenga C, Luo P et al: The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc Natl Acad Sci USA 1999; 96: 1–6.

Xu GL, Bestor TH, Bourc’his D et al: Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 1999; 402: 1–5.

de Greef JC, Wang J, Balog J et al: Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2. Am J Hum Genet 2011; 88: 796–804.

Chouery E, Abou-Ghoch J, Corbani S et al: A novel deletion in ZBTB24 in a Lebanese family with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2. Clin Genet 2012; 82: 1–5.

Jiang YL, Rigolet M, Bourc’his D et al: DNMT3B mutations and DNA methylation defect define two types of ICF syndrome. Hum Mutat 2005; 25: 56–63.

Kanariou M, Petridou E, Liatsis M et al: Age patterns of immunoglobulins G, A & M in healthy children and the influence of breast feeding and vaccination status. Pediatr Allergy Immunol 1995; 6: 24–29.

Comans-Bitter WM, de Groot R, van den Beemd R et al: Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr 1997; 130: 388–393.

Kloeckener-Gruissem B, Betts DR, Zankl A, Berger W, Güngör T : A new and a reclassified ICF patient without mutations in DNMT3B and its interacting proteins SUMO-1 and UBC9. Am J Med Genet 2005; 136: 31–37.

Cerbone M, Wang J, Van der Maarel SM et al: Immunodeficiency, centromeric instability, facial anomalies ICF) syndrome, due to ZBTB24 mutations, presenting with large cerebral cyst. Am J Med Genet 2012; 158A: 1–4.

van den Brand M, Flucke UE, Bult P, Weemaes CM, van Deuren M : Angiosarcoma in a patient with immunodeficiency, centromeric region instability, facial anomalies (ICF) syndrome. Am J Med Genet 2011; 155A: 622–625.

Hultén M : Selective somatic pairing and fragility at 1q12 in a boy with common variable immunodeficiency: a new syndrome. Clin Genet 1978; 14: 294–295.

Gennery AR, Slatter MA, Bredius RG et al: Hematopoietic stem cell transplantation corrects the immunologic abnormalities associated with immunodeficiency-centromeric instability-facial dysmorphism syndrome. Pediatrics 2007; 120: e1341–e1344.

Sekigawa I, Kawasaki M, Ogasawara H et al: DNA methylation: its contribution to systemic lupus erythematosus. Clin Exp Med 2006; 6: 99–106.

Zhu X, Liang J, Li F et al: Analysis of associations between the patterns of global DNA hypomethylation and expression of DNA methyltransferase in patients with systemic lupus erythematosus. Int J Dermatol 2011; 50: 697–704.

Tadokoro Y, Ema H, Okano M, Li E, Nakauchi H : De novo DNA methyltransferase is essential for self-renewal, but not for differentiation, in hematopoietic stem cells. J Exp Med 2007; 204: 715–722.

Jia D, Jurkowska RZ, Zhang X, Jeltsch A, Cheng X : Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. Nature 2007; 449: 248–251.

Ueda Y, Okano M, Williams C et al: Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome. Development 2006; 133: 1183–1192.

Feng J, Chang H, Li E, Fan G : Dynamic expression of de novo DNA methyltransferases Dnmt3a and Dnmt3b in the central nervous system. J Neurosci Res 2005; 79: 734–746.

Tiepolo L, Maraschio P, Gimelli G et al: Multibranched chromosomes 1, 9, and 16 in a patient with combined IgA and IgE deficiency. Hum Genet 1979; 51: 1–11.

Carpenter NJ, Filipovich A, Blaese RM, Carey TL, Berkel AI : Variable immunodeficiency with abnormal condensation of the heterochromatin of chromosomes 1, 9, and 16. J Pediatr 1988; 112: 1–8.

Turleau C, Cabanis M, Girault D et al: Multibranched chromosomes in the ICF syndrome: immunodeficiency, centromeric instability, and facial anomalies. Am J Med Genet 1989; 32: 1–5.

Smeets DF, Moog U, Weemaes CMR et al: ICF syndrome: a new case and review of the literature. Hum Genet 1994; 94: 1–7.

Schuffenhauer S, Bartsch O, Stumm M et al: DNA, FISH and complementation studies in ICF syndrome: DNA hypomethylation of repetitive and single copy loci and evidence for a trans acting factor. Hum Genet 1995; 96: 562–571.

Shirohzu H, Kubota T, Kumazawa A et al: Three novel DNMT3B mutations in Japanese patients with ICF syndrome. Am J Med Genet 2002; 112: 31–37.

Björck EJ, Bui TH, Wijmenga C, Grandell U, Nordenskjöld M : Early prenatal diagnosis of the ICF syndrome. Prenat Diagn 2000; 20: 828–831.

Rigolet M, Grégoire A, Lefort G et al: Early prenatal diagnosis of ICF syndrome by mutation detection. Prenat Diagn 2007; 27: 1075–1078.

Kaya N, Al-Muhsen S, Al-Saud B et al: ICF syndrome in Saudi Arabia: immunological, cytogenetic and molecular analysis. J Clin Immunol 2011; 31: 245–252.

Brown DC, Grace E, Sumner AT, Edmunds AT, Ellis PM : ICF syndrome immunodeficiency, centromeric instability and facial anomalies): investigation of heterochromatin abnormalities and review of clinical outcome. Hum Genet 1995; 96: 1–6.

Schuetz C, Barbi G, Barth TF et al: ICF syndrome: high variability of the chromosomal phenotype and association with classical Hodgkin lymphoma. Am J Med Genet 2007; 143A: 2052–2057.

Gimelli G, Varone P, Pezzolo A, Lerone M, Pistoia V : ICF syndrome with variable expression in sibs. J Med Genet 1993; 30: 1–5.